江蘇恒瑞醫藥股份有限公司公告
17 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

以下哪項陳述 不正確 ？

  • 聯交所和證監會對本公告的內容概不負責。
  • 此公告僅用作向香港公眾人士提供信息。 (correct)
  • 本公告不構成向任何司法權區的公眾提呈出售任何證券的招股章程。
  • 本公司可能不會進行發售或配售。

    • 根據公告，哪些機構對本公告的內容概不負責？

  • 證券及期貨事務監察委員會
  • 香港交易及結算所有限公司
  • 以上所有 (correct)
  • 香港聯合交易所有限公司

    • 根據公告，以下哪項陳述 不正確 ？

  • 本公司證券並未且將不會在美國公開發售。
  • 本公告不構成誘使認購或購買任何證券的要約。
  • 本公司認為其為外國私人發行人。
  • 本公司證券已根據美國證券法登記。 (correct)

    • 本公司向香港公眾提出要約或邀請的唯一文件是：

    <p>招股章程 (D)</p> Signup and view all the answers

    以下哪個機構負責對上市申請進行審批？

    <p>香港聯合交易所有限公司 (B)</p> Signup and view all the answers

    根據公告，本公司在法律上屬於哪種類型的實體？

    <p>股份有限公司 (A)</p> Signup and view all the answers

    本公司是否已經獲得上市批准？

    <p>不是 (B)</p> Signup and view all the answers

    本公告的目的是什么？

    <p>向公眾提供有關新上市公司資訊 (C)</p> Signup and view all the answers

    以下哪項是本公告 不允許 的事項？

    <p>以上所有 (B)</p> Signup and view all the answers

    根據公告，以下哪項 不正確 ？

    <p>本公司在中國的發售將會受到證監會的監管。 (A)</p> Signup and view all the answers

    以下哪項是本公告中所述的 風險 ？

    <p>以上所有 (C)</p> Signup and view all the answers

    根據公告，本公司是否已經成功上市？

    <p>不是 (B)</p> Signup and view all the answers

    誰對本公告的內容負有責任？

    <p>本公司的董事會 (B)</p> Signup and view all the answers

    投資者在作出投資決定前應依賴哪份文件？

    <p>招股章程 (A)</p> Signup and view all the answers

    以下哪項陳述是本公告中 特別強調 的？

    <p>以上所有 (C)</p> Signup and view all the answers

    以下哪項是本公告中 未提及 的？

    <p>以上所有 (D)</p> Signup and view all the answers

    以下哪項是本公告的 主要目的 ？

    <p>提供有关本公司的信息 (D)</p> Signup and view all the answers

    Flashcards

    公告責任聲明

    香港交易所和證監會對公告內容不負責任，無法保證準確性。

    江蘇恒瑞醫藥股份有限公司

    在中國註冊的製藥公司，涉及本公告的主要主體。

    外國私人發行人

    根據美國法，江蘇恒瑞被認定為外國公司。

    上市申請

    本公告涉及的與證券上市有關的申請程序。

    Signup and view all the flashcards

    證券不會公開發售

    證券將不向美國公眾或法律限制區發售。

    Signup and view all the flashcards

    投資決定依據

    投資者需基於招股章程，做出投資決策。

    Signup and view all the flashcards

    法律限制

    根據法律規定，公告發布可能受限。

    Signup and view all the flashcards

    不構成要約

    公告不應被視為推銷證券的邀請。

    Signup and view all the flashcards

    上市文件

    最終上市文件為投資者的主要參考依據。

    Signup and view all the flashcards

    顧問及承銷團

    參與公告及發售過程的專業團隊。

    Signup and view all the flashcards

    責任承擔

    公告的董事對公告準確性共同負責。

    Signup and view all the flashcards

    證券監管機構

    負責監督證券發售的法律機構。

    Signup and view all the flashcards

    香港公眾邀約

    未經批准前不會對香港公眾提出要約。

    Signup and view all the flashcards

    本公告的目的

    僅提供江蘇恒瑞的相關資訊，無其他目的。

    Signup and view all the flashcards

    紀錄於公司註冊處

    公司招股章程需在註冊處登記。

    Signup and view all the flashcards

    Study Notes

    Company Information

    • Company name: Jiangsu Hengrui Pharmaceuticals Co., Ltd. (江蘇恒瑞醫藥股份有限公司)
    • Company type: A limited liability company registered in the People's Republic of China.
    • Purpose of announcement: Providing information to the Hong Kong public, as required by the Hong Kong Exchanges and Clearing Limited (聯交所) and the Securities and Futures Commission of Hong Kong (證券及期貨事務監察委員會).

    Disclaimer and Important Notes

    • The company, its underwriters, lead managers, advisors, or selling group members are not obligated to conduct a sale or offering in Hong Kong or any other jurisdiction, merely because the announcement is published on the Hong Kong Exchanges and Clearing Limited website.
    • The listing application, related public offering, may be accepted, rejected, or returned.
    • The announcement does not constitute an offer to purchase or sell securities, nor does it constitute an inducement to purchase or sell securities.
    • The company or its affiliated parties, or their advisors, or selling group members are not selling any securities or soliciting purchases of securities in any jurisdiction via this announcement.

    Additional Information

    • The announcement is for informational purposes only.
    • This announcement is not intended for use in, nor does it constitute, an offer or sale of securities in the United States or any other jurisdiction where such an offer or sale would be unlawful.
    • This company is not registered with U.S. Securities and Exchange Commission (SEC), nor any state/local securities authorities.
    • Any sales of securities in the United States must comply with US securities laws.
    • The company will comply with US securities law if they engage in a public offering to avoid violations.
    • The announcement does not constitute a prospectus or offering document, and is not intended to encourage purchases.
    • Any investment decisions should not be based solely on this announcement. Final listing documents are the definitive source for investment decisions.
    • The listing application has not been approved.

    Announcement Details

    • The issuance of this announcement may be subject to restrictions in certain jurisdictions.

    Contact Information

    • The company's contact details will be available in the registration documents.

    Additional Information

    • Company is listed on the Hong Kong Exchanges and Clearing Limited, and adheres to rules laid out.
    • Further information regarding the announcement’s content and details will be specified in official documents to be released later.
    • Names of directors associated with the company are listed.
    • The document is dated January 6, 2025.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Jiangsu Hengrui Pharmaceuticals Co., Ltd. PDF

    Description

    本公告旨在向香港公眾提供有關江蘇恒瑞醫藥股份有限公司的資訊。公告符合香港交易所和香港證券及期貨事務監察委員會的要求，並告知讀者有關上市申請和公眾發行的注意事項。公告不構成購買或出售證券的要約。

    More Like This

    고구려의 발전과 주요 왕들
    9 questions

    고구려의 발전과 주요 왕들

    NavigableHeliotrope4987 avatar
    NavigableHeliotrope4987
    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser